524632 — Shukra Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapTurnaround

Annual balance sheet for Shukra Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	1.26	5.04	0.854	39.7	99.8
Net Total Accounts Receivable
Net Total Receivables	127	132	105	327	268
Total Inventory
Total Other Current Assets
Total Current Assets	145	161	157	531	562
Net Property, Plant And Equipment	190	194	192	219	216
Long Term Investments
Total Assets	335	356	351	750	778
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	69.9	70.3	124	425	142
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	181	200	188	497	202
Common Stock
Additional Paid In Capital
Other Equity
Total Equity	154	156	164	253	576
Total Liabilities & Shareholders' Equity	335	356	351	750	778
Total Common Shares Outstanding